输血相关性急性肺损伤（TRALI）是发生于输血期间或输血后的罕见并发症，以急性缺氧和非心源性肺水肿为特点，因死亡率高（5%~10%）而越来越受到临床关注[1]，据2004年美国食品药品管理局（FDA）的数据，TRALI为输血相关性死亡的首要因素[2]。根据文献资料，输注血制品、含血浆制品、新鲜冰冻血浆（FFP）和血小板的TRALI发生率分别约为1/5 000[3]，1/2 000[4]，1/7 900[5]和1/432[6]。据报道，所有血制品（除白蛋白外）均可引起TRALI[7]，甚至有作者怀疑大剂量给予白细胞介素-2（IL-2）也可能导致TRALI[8]。目前，我国有关TRALI的报道较少，仅有个别死亡案例报道[9，10]，而相关的研究报道很少，这可能与我们尚未认识到TRALI的危险性，以及对其的诊断率较低有关。
Objectives To explore the efficacy of humidified and heated high flow oxygen therapy for the critically ill patients in intensive care unit (ICU) after extubation. Methods From January 2014 to December 2016, 487 patients were enrolled. Patients were allocated to two treatment groups randomly, which were humidified and heated high flow oxygen therapy group (236 patients, HFM group, aged 55.3±21.1 years old) and routine oxygen therapy group (251 patients, TO group, aged 58.4±19.3 years old). Blood oxygen saturation, arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), fraction of inspired oxygen (FiO2), respiratory frequency, incidence rate of reintubation, ventilator-free days, ICU length of stay, and hospital stay were assessed and compared between the HFM group and the TO group. Results The hospital stay was similar in two groups. There were more ventilator-free days in the HFM group (P<0.05), fewer patients required reintubation (4.2%vs. 10.4%, P<0.05) and less ICU length of stay [(10.5±6.1) dvs. (14.3±8.5) d, P<0.05]. PaO2/FiO2 of the HFM group were better than the TO group after extubation at 2 h, 4 h, 8 h, 24 h, and 48 h (P<0.05). There were no statistically significant differences in respiratory frequency and PaCO2. Conclusions Humidified and heated high flow oxygen therapy can supply a better oxygenation for patients after extubation in ICU. It could be a common therapy in ICU for the critically patients after extubation.